Sfoglia per Autore
Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naive to the antiretroviral drugs
2009-01-01 Alteri, C; Svicher, V; Gori, C; D'Arrigo, R; Ciccozzi, M; CECCHERINI SILBERSTEIN, F; Selleri, M; Bardacci, S; Giuliani, M; Elia, P; Scognamiglio, P; Balzano, R; Orchi, N; Girardi, E; Perno, Cf; Capobianchi, M; De Carli, G; Galati, V; Grisetti, S; Navarra, A; Nicastri, E; Pittalis, S; Puro, V; Sampaolesi, A; Nurra, G; Selleri, M; Zaccarelli, M; Zaniratti, M; Di Carlo, A; Giuliani, M; De Filippis, A; Brancatella, R; Maggi, T; Gattari, P; Spizzichino, L; Schito, S; Sarmati, L; Battagin, G; Tacconi, L; Gallo, I; Anzalone, E; Pitorri, A; Caterini, A; Barbacci, S
Molecular dynamics and free energy studies on the wild-type and mutated hiv-1 protease complexed with four approved drugs: Mechanism of binding and drug resistance
2009-01-01 Alcaro, S; Artese, A; CECCHERINI SILBERSTEIN, F; Ortuso, F; Perno, Cf; Sing, T; Svicher, V
Dynamics of NRTI resistance mutations during therapy interruption
2009-01-01 Trignetti, M; Sing, T; Svicher, V; Santoro, M; Forbici, F; D'Arrigo, R; Bellocchi, M; Santoro, M; Marconi, P; Zaccarelli, M; Trotta, M; Bellagamba, R; Narciso, P; Antinori, A; Lengauer, T; Perno, Cf; CECCHERINI SILBERSTEIN, F
The profile of mutational clusters associated with lamivudine resistance can be constrained by HBV genotypes
2009-03-01 Svicher, V; Gori, C; Trignetti, M; Visca, M; Micheli, V; Bernassola, M; Salpini, R; Gubertini, G; Longo, R; Niero, F; CECCHERINI SILBERSTEIN, F; De Sanctis, G; Spanò, A; Cappiello, G; Perno, Cf
Treatment with the fusion inhibitor enfuvirtide influences the appearance of mutations in the human immunodeficiency virus type 1 regulatory protein rev
2009-07-01 Svicher, V; Alteri, C; D'Arrigo, R; Laganà, A; Trignetti, M; Lo Caputo, S; Callegaro, A; Maggiolo, F; Mazzotta, F; Ferro, A; Dimonte, S; Aquaro, S; di Perri, G; Bonora, S; Tommasi, C; Trotta, M; Narciso, P; Antinori, A; Perno, Cf; CECCHERINI SILBERSTEIN, F
Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group
2010-07-01 Svicher, V; D'Arrigo, R; Alteri, C; Andreoni, M; Angarano, G; Antinori, A; Antonelli, G; Bagnarelli, P; Baldanti, F; Bertoli, A; Borderi, M; Boeri, E; Bonn, I; Bruzzone, B; Callegaro, A; Cammarota, R; Canducci, F; CECCHERINI SILBERSTEIN, F; Clementi, M; Monforte, A; De Luca, A; Di Biagio, A; Di Gianbenedetto, S; Di Perri, G; Di Pietro, M; Fabeni, L; Fadda, G; Galli, M; Gennari, W; Ghisetti, V; Giacometti, A; Gori, A; Leoncini, F; Maggiolo, F; Maserati, R; Mazzotta, F; Micheli, V; Meini, G; Monno, L; Mussini, C; Nozza, S; Paolucci, S; Parisi, S; Pecorari, M; Pizzi, D; Quirino, T; Re, M; Rizzardini, G; Santangelo, R; Soria, A; Stazi, F; Sterrantino, G; Turriziani, O; Viscoli, C; Vullo, V; Lazzarin, A; Perno, Cf
Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens.
2010-11-01 Svicher, V; Alteri, C; Artese, A; Forbici, F; Santoro, M; Schols, D; Van Laethem, K; Alcaro, S; Costa, G; Tommasi, C; Zaccarelli, M; Narciso, P; Antinori, A; CECCHERINI SILBERSTEIN, F; Balzarini, J; Perno, Cf
Specific HIV-1 integrase polymorphisms change their prevalence in untreated versus antiretroviral-treated HIV-1-infected patients, all naive to integrase inhibitors
2010-11-01 CECCHERINI SILBERSTEIN, F; Malet, I; Fabeni, L; Dimonte, S; Svicher, V; D'Arrigo, R; Artese, A; Costa, G; Bono, S; Alcaro, S; Monforte, A; Katlama, C; Calvez, V; Antinori, A; Marcelin, A; Perno, Cf
Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens
2010-11-01 Svicher, V; Alteri, C; Artese, A; Forbici, F; Santoro, M; Schols, D; Van Laethem, K; Alcaro, S; Costa, G; Tommasi, C; Zaccarelli, M; Narciso, P; Antinori, A; CECCHERINI SILBERSTEIN, F; Balzarini, J; Perno, Cf
Lamivudine-resistance mutations can be selected even at very low levels of hepatitis B viraemia
2010-12-01 Svicher, V; Alteri, C; Gori, C; Salpini, R; Marcuccilli, F; Bertoli, A; Longo, R; Bernassola, M; Gallinaro, V; Romano, S; Visca, M; Ursitti, A; Feasi, M; Micheli, V; Angelico, M; Cassola, G; Parruti, G; Gubertini, G; De Sanctis, G; CECCHERINI SILBERSTEIN, F; Cappiello, G; Spanò, A; Perno, Cf
Key genetic elements in HIV-1 gp120 V1,V2 and C4 domains tightly and differentially modulate gp120 interaction with the CCR5 and CXCR4 N terminus and HIV-1 antigenetic Potential
2011-01-01 Svicher, V; Chen, M; Alteri, C; Costa, G; Dimonte, S; Chang, L; Parrotta, L; Dimaio, C; Surdo, M; Saccomandi, P; Alcaro, S; CECCHERINI SILBERSTEIN, F; Artese, A; Zhang, J; Perno, Cf
Key genetic elements in HIV-1 gp120 V1,V2 and C4 domains tightly and differentially modulate gp120 interaction with the CCR5 and CXCR4 N terminus and HIV-1 antigenetic Potential
2011-01-01 Svicher, V; Chen, M; Alteri, C; Costa, G; Dimonte, S; Chang, L; Parrotta, L; Dimaio, C; Surdo, M; Saccomandi, P; Alcaro, S; CECCHERINI SILBERSTEIN, F; Artese, A; Zhang, J; Perno, Cf
Specific HbsAg genetic determinants are associated with occult HBV infection in vivo and HbsAg detection
2011-01-01 Svicher, V; Cento, V; Bernassola, M; Neumann Fraune, M; Chen, M; Salpini, R; Chang, L; Longo, R; Visca, M; Romano, S; Micheli, V; Bertoli, A; Gubertini, G; Marino, N; Mazzotta, F; Sarrecchia, C; Andreoni, M; Angelico, M; Ursitti, A; Spanò, A; CECCHERINI SILBERSTEIN, F; Zhan, J; Verheyen, J; Cappiello, G; Perno, Cf
Specific HBSAG Genetic- Determinants are associated with occult HBV-infection in vivo and HBSAG detection
2011-01-01 Svicher, V; Cento, V; Bernassola, M; Neumann Fraune, M; Salpini, R; Longo, R; Visca, M; Romano, S; Michieli, V; Bertoli, A; Gubertini, G; Marino, N; Mazzotta, F; Sarrecchia, C; Andreoni, M; Angelico, M; Ursitti, A; Spanò, A; CECCHERINI SILBERSTEIN, F; Verheyen, J; Cappiello, G; Perno, Cf
Identification and structural characterization of novel genetic elements in the HIV-1 V3 loop regulating coreceptor usage
2011-01-01 Svicher, V; Alteri, C; Artese, A; Zhang, J; Costa, G; Mercurio, F; D'Arrigo, R; Alcaro, S; Palù, G; Clementi, M; Zazzi, M; Andreoni, M; Antinori, A; Lazzarin, A; CECCHERINI SILBERSTEIN, F; Perno, Cf
Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance.
2011-01-01 Sarrecchia, C; Svicher, V; Volpi, A; Salpini, R; Ceccarelli, L; Sordillo, P; Bertoli, A; Perno, Cf; Andreoni, M
The Lowest X4 Geno2Pheno-False Positive Rate Is Associated with Greater CD4-Depletion
2011-01-01 Santoro, M; Armenia, D; Fabeni, L; Santoro, M; Gori, C; Forbici, F; Cento, V; Svicher, V; Bertoli, A; Dori, L; Andreoni, M; Narciso, P; Antinori, A; CECCHERINI SILBERSTEIN, F; Perno, Cf
Overlapping Structure of HBV genome and immune selecting pressure are the main driving forces for HBV evolution
2011-01-01 Cento, V; Mirabelli, C; Salpini, R; Han, Y; Mercurio, F; Dimonte, S; Beggel, B; Wittkop, L; Fraune, M; Gori, C; Bertoli, A; Micheli, V; Guberino, G; Longo, R; Romano, S; Visca, M; Gallinaro, V; Marino, M; Mazzotta, F; De Sanctis, G; Tremulet, P; Angelico, M; Zhang, X; Verheyen, J; CECCHERINI SILBERSTEIN, F; Perno, Cf; Svicher, V
Dual mixed (but not X4) tropic-HIV-1 isolates can replicate in human primary macrophages and are inhibited by CCR5- inhibitors
2011-01-01 Surdo, M; Balestra, E; Saccomandi, P; Di Santo, F; Svicher, V; Alteri, C; Cento, V; Pollicita, M; Scopelliti, F; Andreoni, M; Aquaro, S; CECCHERINI SILBERSTEIN, F; Perno, Cf
HIV-1 R5+ /X4- tropic viruses can be inhibited in vitro as well as in vivo by maraviroc: a refined analysis of patients enrolled in the Phase IIb study A4001029
2011-01-01 CECCHERINI SILBERSTEIN, F; Surdo, M; Alteri, C; Puertas, M; Saccomandi, P; Artese, A; Balestra, E; Chapman, D; Lewis, M; Valdez, H; Clotet, B; Alcaro, S; Santoro, M; Svicher, V; Martinez Picado, J; Perno, Cf
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2009 | Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naive to the antiretroviral drugs | Alteri, C; Svicher, V; Gori, C; D'Arrigo, R; Ciccozzi, M; CECCHERINI SILBERSTEIN, F; Selleri, M; Bardacci, S; Giuliani, M; Elia, P; Scognamiglio, P; Balzano, R; Orchi, N; Girardi, E; Perno, Cf; Capobianchi, M; De Carli, G; Galati, V; Grisetti, S; Navarra, A; Nicastri, E; Pittalis, S; Puro, V; Sampaolesi, A; Nurra, G; Selleri, M; Zaccarelli, M; Zaniratti, M; Di Carlo, A; Giuliani, M; De Filippis, A; Brancatella, R; Maggi, T; Gattari, P; Spizzichino, L; Schito, S; Sarmati, L; Battagin, G; Tacconi, L; Gallo, I; Anzalone, E; Pitorri, A; Caterini, A; Barbacci, S | Articolo su rivista | |
| 1-gen-2009 | Molecular dynamics and free energy studies on the wild-type and mutated hiv-1 protease complexed with four approved drugs: Mechanism of binding and drug resistance | Alcaro, S; Artese, A; CECCHERINI SILBERSTEIN, F; Ortuso, F; Perno, Cf; Sing, T; Svicher, V | Articolo su rivista | |
| 1-gen-2009 | Dynamics of NRTI resistance mutations during therapy interruption | Trignetti, M; Sing, T; Svicher, V; Santoro, M; Forbici, F; D'Arrigo, R; Bellocchi, M; Santoro, M; Marconi, P; Zaccarelli, M; Trotta, M; Bellagamba, R; Narciso, P; Antinori, A; Lengauer, T; Perno, Cf; CECCHERINI SILBERSTEIN, F | Articolo su rivista | |
| 1-mar-2009 | The profile of mutational clusters associated with lamivudine resistance can be constrained by HBV genotypes | Svicher, V; Gori, C; Trignetti, M; Visca, M; Micheli, V; Bernassola, M; Salpini, R; Gubertini, G; Longo, R; Niero, F; CECCHERINI SILBERSTEIN, F; De Sanctis, G; Spanò, A; Cappiello, G; Perno, Cf | Articolo su rivista | |
| 1-lug-2009 | Treatment with the fusion inhibitor enfuvirtide influences the appearance of mutations in the human immunodeficiency virus type 1 regulatory protein rev | Svicher, V; Alteri, C; D'Arrigo, R; Laganà, A; Trignetti, M; Lo Caputo, S; Callegaro, A; Maggiolo, F; Mazzotta, F; Ferro, A; Dimonte, S; Aquaro, S; di Perri, G; Bonora, S; Tommasi, C; Trotta, M; Narciso, P; Antinori, A; Perno, Cf; CECCHERINI SILBERSTEIN, F | Articolo su rivista | |
| 1-lug-2010 | Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group | Svicher, V; D'Arrigo, R; Alteri, C; Andreoni, M; Angarano, G; Antinori, A; Antonelli, G; Bagnarelli, P; Baldanti, F; Bertoli, A; Borderi, M; Boeri, E; Bonn, I; Bruzzone, B; Callegaro, A; Cammarota, R; Canducci, F; CECCHERINI SILBERSTEIN, F; Clementi, M; Monforte, A; De Luca, A; Di Biagio, A; Di Gianbenedetto, S; Di Perri, G; Di Pietro, M; Fabeni, L; Fadda, G; Galli, M; Gennari, W; Ghisetti, V; Giacometti, A; Gori, A; Leoncini, F; Maggiolo, F; Maserati, R; Mazzotta, F; Micheli, V; Meini, G; Monno, L; Mussini, C; Nozza, S; Paolucci, S; Parisi, S; Pecorari, M; Pizzi, D; Quirino, T; Re, M; Rizzardini, G; Santangelo, R; Soria, A; Stazi, F; Sterrantino, G; Turriziani, O; Viscoli, C; Vullo, V; Lazzarin, A; Perno, Cf | Articolo su rivista | |
| 1-nov-2010 | Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens. | Svicher, V; Alteri, C; Artese, A; Forbici, F; Santoro, M; Schols, D; Van Laethem, K; Alcaro, S; Costa, G; Tommasi, C; Zaccarelli, M; Narciso, P; Antinori, A; CECCHERINI SILBERSTEIN, F; Balzarini, J; Perno, Cf | Articolo su rivista | |
| 1-nov-2010 | Specific HIV-1 integrase polymorphisms change their prevalence in untreated versus antiretroviral-treated HIV-1-infected patients, all naive to integrase inhibitors | CECCHERINI SILBERSTEIN, F; Malet, I; Fabeni, L; Dimonte, S; Svicher, V; D'Arrigo, R; Artese, A; Costa, G; Bono, S; Alcaro, S; Monforte, A; Katlama, C; Calvez, V; Antinori, A; Marcelin, A; Perno, Cf | Articolo su rivista | |
| 1-nov-2010 | Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens | Svicher, V; Alteri, C; Artese, A; Forbici, F; Santoro, M; Schols, D; Van Laethem, K; Alcaro, S; Costa, G; Tommasi, C; Zaccarelli, M; Narciso, P; Antinori, A; CECCHERINI SILBERSTEIN, F; Balzarini, J; Perno, Cf | Articolo su rivista | |
| 1-dic-2010 | Lamivudine-resistance mutations can be selected even at very low levels of hepatitis B viraemia | Svicher, V; Alteri, C; Gori, C; Salpini, R; Marcuccilli, F; Bertoli, A; Longo, R; Bernassola, M; Gallinaro, V; Romano, S; Visca, M; Ursitti, A; Feasi, M; Micheli, V; Angelico, M; Cassola, G; Parruti, G; Gubertini, G; De Sanctis, G; CECCHERINI SILBERSTEIN, F; Cappiello, G; Spanò, A; Perno, Cf | Articolo su rivista | |
| 1-gen-2011 | Key genetic elements in HIV-1 gp120 V1,V2 and C4 domains tightly and differentially modulate gp120 interaction with the CCR5 and CXCR4 N terminus and HIV-1 antigenetic Potential | Svicher, V; Chen, M; Alteri, C; Costa, G; Dimonte, S; Chang, L; Parrotta, L; Dimaio, C; Surdo, M; Saccomandi, P; Alcaro, S; CECCHERINI SILBERSTEIN, F; Artese, A; Zhang, J; Perno, Cf | Altro | |
| 1-gen-2011 | Key genetic elements in HIV-1 gp120 V1,V2 and C4 domains tightly and differentially modulate gp120 interaction with the CCR5 and CXCR4 N terminus and HIV-1 antigenetic Potential | Svicher, V; Chen, M; Alteri, C; Costa, G; Dimonte, S; Chang, L; Parrotta, L; Dimaio, C; Surdo, M; Saccomandi, P; Alcaro, S; CECCHERINI SILBERSTEIN, F; Artese, A; Zhang, J; Perno, Cf | Intervento a convegno | |
| 1-gen-2011 | Specific HbsAg genetic determinants are associated with occult HBV infection in vivo and HbsAg detection | Svicher, V; Cento, V; Bernassola, M; Neumann Fraune, M; Chen, M; Salpini, R; Chang, L; Longo, R; Visca, M; Romano, S; Micheli, V; Bertoli, A; Gubertini, G; Marino, N; Mazzotta, F; Sarrecchia, C; Andreoni, M; Angelico, M; Ursitti, A; Spanò, A; CECCHERINI SILBERSTEIN, F; Zhan, J; Verheyen, J; Cappiello, G; Perno, Cf | Intervento a convegno | |
| 1-gen-2011 | Specific HBSAG Genetic- Determinants are associated with occult HBV-infection in vivo and HBSAG detection | Svicher, V; Cento, V; Bernassola, M; Neumann Fraune, M; Salpini, R; Longo, R; Visca, M; Romano, S; Michieli, V; Bertoli, A; Gubertini, G; Marino, N; Mazzotta, F; Sarrecchia, C; Andreoni, M; Angelico, M; Ursitti, A; Spanò, A; CECCHERINI SILBERSTEIN, F; Verheyen, J; Cappiello, G; Perno, Cf | Intervento a convegno | |
| 1-gen-2011 | Identification and structural characterization of novel genetic elements in the HIV-1 V3 loop regulating coreceptor usage | Svicher, V; Alteri, C; Artese, A; Zhang, J; Costa, G; Mercurio, F; D'Arrigo, R; Alcaro, S; Palù, G; Clementi, M; Zazzi, M; Andreoni, M; Antinori, A; Lazzarin, A; CECCHERINI SILBERSTEIN, F; Perno, Cf | Articolo su rivista | |
| 1-gen-2011 | Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance. | Sarrecchia, C; Svicher, V; Volpi, A; Salpini, R; Ceccarelli, L; Sordillo, P; Bertoli, A; Perno, Cf; Andreoni, M | Articolo su rivista | |
| 1-gen-2011 | The Lowest X4 Geno2Pheno-False Positive Rate Is Associated with Greater CD4-Depletion | Santoro, M; Armenia, D; Fabeni, L; Santoro, M; Gori, C; Forbici, F; Cento, V; Svicher, V; Bertoli, A; Dori, L; Andreoni, M; Narciso, P; Antinori, A; CECCHERINI SILBERSTEIN, F; Perno, Cf | Intervento a convegno | |
| 1-gen-2011 | Overlapping Structure of HBV genome and immune selecting pressure are the main driving forces for HBV evolution | Cento, V; Mirabelli, C; Salpini, R; Han, Y; Mercurio, F; Dimonte, S; Beggel, B; Wittkop, L; Fraune, M; Gori, C; Bertoli, A; Micheli, V; Guberino, G; Longo, R; Romano, S; Visca, M; Gallinaro, V; Marino, M; Mazzotta, F; De Sanctis, G; Tremulet, P; Angelico, M; Zhang, X; Verheyen, J; CECCHERINI SILBERSTEIN, F; Perno, Cf; Svicher, V | Intervento a convegno | |
| 1-gen-2011 | Dual mixed (but not X4) tropic-HIV-1 isolates can replicate in human primary macrophages and are inhibited by CCR5- inhibitors | Surdo, M; Balestra, E; Saccomandi, P; Di Santo, F; Svicher, V; Alteri, C; Cento, V; Pollicita, M; Scopelliti, F; Andreoni, M; Aquaro, S; CECCHERINI SILBERSTEIN, F; Perno, Cf | Intervento a convegno | |
| 1-gen-2011 | HIV-1 R5+ /X4- tropic viruses can be inhibited in vitro as well as in vivo by maraviroc: a refined analysis of patients enrolled in the Phase IIb study A4001029 | CECCHERINI SILBERSTEIN, F; Surdo, M; Alteri, C; Puertas, M; Saccomandi, P; Artese, A; Balestra, E; Chapman, D; Lewis, M; Valdez, H; Clotet, B; Alcaro, S; Santoro, M; Svicher, V; Martinez Picado, J; Perno, Cf | Intervento a convegno |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile